The Evolving Regulatory Landscape for Clinical Trials in India
Mark Barnes, Jamie Flaherty, Minal Caron, Alishan Naqvee, & Barbara Bierer, Fall 2018
Since 2013, India has undergone a significant regulatory transformation in regard to clinical trials. Continue Reading
No Longer Business as Usual: FDA Exceptionalism, Commercial Speech, and the First Amendment
Carl Wiersum, Fall 2018
FDA’s crucial mission of protecting the safety and integrity of our nation’s food and drug supply has led to several areas… Continue Reading
The Food and Drug Law Journal (FDLJ) has led the academic and practical discussions of the law regarding food, drugs, cosmetics, biologics, and medical devices for seventy years.
Published quarterly by the not-for-profit and non-partisan Food and Drug Law Institute (FDLI), the peer-reviewed FDLJ is the only forum exclusively dedicated to food, drugs, and related areas.
From the Third Circuit to the Supreme Court, jurists have cited and relied upon its scholarship in order to understand this complicated and expanding area of law. Similarly, professors, practitioners, physicians, and policymakers rely on the FDLJ for insight into how the law has changed, and where the law is heading.